Boston Trust Walden Corp Prestige Consumer Healthcare Inc. Transaction History
Boston Trust Walden Corp
- $14.1 Billion
- Q3 2024
A detailed history of Boston Trust Walden Corp transactions in Prestige Consumer Healthcare Inc. stock. As of the latest transaction made, Boston Trust Walden Corp holds 579,538 shares of PBH stock, worth $45.6 Million. This represents 0.3% of its overall portfolio holdings.
Number of Shares
579,538Holding current value
$45.6 Million% of portfolio
0.3%Shares
1 transactions
Others Institutions Holding PBH
# of Institutions
338Shares Held
50.2MCall Options Held
6.3KPut Options Held
0-
Black Rock Inc. New York, NY8.28MShares$651 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.68MShares$447 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.96MShares$233 Million0.05% of portfolio
-
Ariel Investments, LLC Chicago, IL2.78MShares$219 Million2.25% of portfolio
-
Macquarie Group LTD Australia, C32.67MShares$211 Million0.21% of portfolio
About Prestige Consumer Healthcare Inc.
- Ticker PBH
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,762,600
- Market Cap $3.92B
- Description
- Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's an...